PDEX Pro Dex Inc
Price (delayed)
$55.19
Market cap
$179.98M
P/E Ratio
27.05
Dividend/share
N/A
EPS
$2.04
Enterprise value
$197.24M
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. It
Highlights
Pro Dex's EPS has surged by 140% YoY and by 32% QoQ
PDEX's net income has surged by 125% year-on-year and by 30% since the previous quarter
PDEX's P/E is 51% above its 5-year quarterly average of 16.7 but 3.8% below its last 4 quarters average of 26.2
The quick ratio has declined by 33% year-on-year and by 29% since the previous quarter
Pro Dex's debt has increased by 28% YoY and by 19% QoQ
Key stats
What are the main financial stats of PDEX
Market
Valuations
Earnings
Shares outstanding
3.26M
Market cap
$179.98M
Enterprise value
$197.24M
Price to earnings (P/E)
27.05
Price to book (P/B)
5.65
Price to sales (P/S)
2.95
EV/EBIT
21
EV/EBITDA
18.61
EV/Sales
3.23
Revenue
$61M
Gross profit
$18.31M
Operating income
$10.27M
Net income
$6.75M
EBIT
$9.39M
EBITDA
$10.6M
Free cash flow
$1.64M
Per share
Balance sheet
Liquidity
EPS
$2.04
EPS diluted
$2
Free cash flow per share
$0.5
Book value per share
$9.76
Revenue per share
$18.71
TBVPS
$18.5
Total assets
$60.37M
Total liabilities
$28.55M
Debt
$17.33M
Equity
$31.82M
Working capital
$27.16M
Debt to equity
0.54
Current ratio
2.58
Quick ratio
1.35
Net debt/EBITDA
1.63
Margins
Efficiency
Dividend
EBITDA margin
17.4%
Gross margin
30%
Net margin
11.1%
Operating margin
16.8%
Return on assets
12.4%
Return on equity
21.7%
Return on invested capital
17.5%
Return on capital employed
21.7%
Return on sales
15.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PDEX stock price
How has the Pro Dex stock price performed over time
Intraday
7.37%
1 week
11.7%
1 month
58.96%
1 year
210.93%
YTD
18.05%
QTD
11.32%
Financial performance
How have Pro Dex's revenue and profit performed over time
Revenue
$61M
Gross profit
$18.31M
Operating income
$10.27M
Net income
$6.75M
Gross margin
30%
Net margin
11.1%
PDEX's net income has surged by 125% year-on-year and by 30% since the previous quarter
Pro Dex's net margin has surged by 79% YoY and by 21% QoQ
PDEX's operating income has surged by 63% year-on-year and by 23% since the previous quarter
Pro Dex's gross profit has increased by 34% YoY and by 14% from the previous quarter
Growth
What is Pro Dex's growth rate over time
Valuation
What is Pro Dex stock price valuation
P/E
27.05
P/B
5.65
P/S
2.95
EV/EBIT
21
EV/EBITDA
18.61
EV/Sales
3.23
Pro Dex's EPS has surged by 140% YoY and by 32% QoQ
PDEX's P/E is 51% above its 5-year quarterly average of 16.7 but 3.8% below its last 4 quarters average of 26.2
PDEX's price to book (P/B) is 70% higher than its last 4 quarters average of 3.1 and 55% higher than its 5-year quarterly average of 3.4
PDEX's equity is up by 3.1% since the previous quarter
The stock's price to sales (P/S) is 62% more than its last 4 quarters average of 1.7 and 45% more than its 5-year quarterly average of 1.9
PDEX's revenue is up by 26% YoY and by 7% QoQ
Efficiency
How efficient is Pro Dex business performance
The return on equity has surged by 117% year-on-year and by 30% since the previous quarter
Pro Dex's return on assets has surged by 107% YoY and by 24% QoQ
Pro Dex's ROIC has soared by 101% YoY and by 23% from the previous quarter
Pro Dex's return on sales has surged by 64% YoY and by 18% QoQ
Dividends
What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PDEX.
Financial health
How did Pro Dex financials performed over time
The total assets is 111% greater than the total liabilities
PDEX's total liabilities is up by 45% YoY and by 22% QoQ
The quick ratio has declined by 33% year-on-year and by 29% since the previous quarter
Pro Dex's debt is 46% lower than its equity
Pro Dex's debt to equity has increased by 29% YoY and by 15% from the previous quarter
Pro Dex's debt has increased by 28% YoY and by 19% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.